 Ventricular Dysfunction, Left
"Ventricular Dysfunction, Left" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Descriptor ID |
D018487
|
| MeSH Number(s) |
C14.280.945.900
|
| Concept/Terms |
Ventricular Dysfunction, Left- Ventricular Dysfunction, Left
- Left Ventricular Dysfunction
- Dysfunction, Left Ventricular
- Dysfunctions, Left Ventricular
- Left Ventricular Dysfunctions
- Ventricular Dysfunctions, Left
|
Below are MeSH descriptors whose meaning is more general than "Ventricular Dysfunction, Left".
Below are MeSH descriptors whose meaning is more specific than "Ventricular Dysfunction, Left".
This graph shows the total number of publications written about "Ventricular Dysfunction, Left" by people in this website by year, and whether "Ventricular Dysfunction, Left" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 2 | 1 | 3 | | 1999 | 1 | 1 | 2 | | 2000 | 2 | 0 | 2 | | 2001 | 1 | 1 | 2 | | 2002 | 1 | 0 | 1 | | 2003 | 3 | 6 | 9 | | 2004 | 4 | 2 | 6 | | 2005 | 5 | 6 | 11 | | 2006 | 3 | 4 | 7 | | 2007 | 4 | 3 | 7 | | 2008 | 6 | 1 | 7 | | 2010 | 12 | 1 | 13 | | 2011 | 6 | 4 | 10 | | 2012 | 5 | 3 | 8 | | 2013 | 8 | 1 | 9 | | 2014 | 9 | 5 | 14 | | 2015 | 10 | 3 | 13 | | 2016 | 6 | 2 | 8 | | 2017 | 4 | 3 | 7 | | 2018 | 9 | 4 | 13 | | 2019 | 11 | 2 | 13 | | 2020 | 9 | 2 | 11 | | 2021 | 7 | 0 | 7 | | 2022 | 7 | 1 | 8 | | 2023 | 9 | 0 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Ventricular Dysfunction, Left" by people in Profiles.
-
Montembeau SC, Rao BR, Mitchell AR, Speight CD, Allen LA, Halpern SD, Ko YA, Matlock DD, Moore MA, Morris AA, Scherer LD, Ubel P, Dickert NW. Integrating Cost into Shared Decision-Making for Heart Failure with Reduced Ejection Fraction (POCKET-COST-HF): A Trial Providing Out-of-Pocket Costs for Heart Failure Medications during Clinical Encounters. Am Heart J. 2024 03; 269:84-93.
-
Krantz MJ, Watters A, Oakes J, Frazier M, Mehler PS. Myocardial mechanics and cardiac biomarkers in adults with severe anorexia nervosa. J Echocardiogr. 2024 Jun; 22(2):79-87.
-
Buchanan C, Buchanan C, Riordan M, Byrd J, Schulte M, Kohrt WM, Ambardekar AV, Allen LA, Wolfel G, Lawley J, Levine BD, Cornwell WK. Cardiopulmonary Performance Among?Heart?Failure Patients Before?and?After Left Ventricular Assist?Device?Implantation. JACC Heart Fail. 2024 01; 12(1):117-129.
-
Cannie DE, Protonotarios A, Bakalakos A, Syrris P, Lorenzini M, De Stavola B, Bjerregaard L, Dybro AM, Hey TM, Hansen FG, Navarro Pe?alver M, Crespo-Leiro MG, Larra?aga-Moreira JM, de Frutos F, Johnson R, Slater TA, Monserrat L, Sengupta A, Mestroni L, Taylor MRG, Sinagra G, Bilinska Z, Solla-Ruiz I, Arana Achaga X, Barriales-Villa R, Garcia-Pavia P, Gimeno JR, Dal Ferro M, Merlo M, Wahbi K, Fatkin D, Mogensen J, Rasmussen TB, Elliott PM. Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants. Circ Genom Precis Med. 2023 10; 16(5):434-441.
-
Swat SA, Helmkamp LJ, Tietbohl C, Thompson JS, Fitzgerald M, McIlvennan CK, Harger G, Ho PM, Ahmad FS, Ahmad T, Buttrick P, Allen LA. Clinical Inertia Among Outpatients With?Heart?Failure: Application of Treatment Nonintensification Taxonomy to?EPIC-HF Trial. JACC Heart Fail. 2023 11; 11(11):1579-1591.
-
Pierce JB, Blumer V, Choi S, Hardy NC, Greiner MA, Carnicelli AP, Shen X, Lippmann SJ, Peterson PN, Allen LA, Fonarow GC, Mentz RJ, Greene SJ, O'Brien EC. Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Na?ve to Renin-Angiotensin System Inhibitors. Am J Cardiol. 2023 10 01; 204:151-158.
-
Pierce JB, Vaduganathan M, Fonarow GC, Ikeaba U, Chiswell K, Butler J, DeVore AD, Heidenreich PA, Huang JC, Kittleson MM, Joynt Maddox KE, Linganathan KK, McDermott JJ, Owens AT, Peterson PN, Solomon SD, Vardeny O, Yancy CW, Greene SJ. Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2023 07 01; 8(7):652-661.
-
Swat SA, Xu H, Allen LA, Greene SJ, DeVore AD, Matsouaka RA, Goyal P, Peterson PN, Hernandez AF, Krumholz HM, Yancy CW, Fonarow GC, Hess PL. Opportunities and Achievement of Medication Initiation Among Inpatients With Heart?Failure With Reduced Ejection?Fraction. JACC Heart Fail. 2023 08; 11(8 Pt 1):918-929.
-
Oneglia AP, Szczepaniak LS, Jaffery MF, Cipher DJ, McDonald JG, Haykowsky MJ, Moreau KL, Clegg DJ, Zaha V, Nelson MD. Myocardial steatosis impairs left ventricular diastolic-systolic coupling in healthy humans. J Physiol. 2023 04; 601(8):1371-1382.
-
Edward JA, Parker H, St?hr EJ, McDonnell BJ, O'Gean K, Schulte M, Lawley JS, Cornwell WK. Exertional Cardiac and Pulmonary Vascular Hemodynamics in Patients With Heart Failure With Reduced Ejection Fraction. J Card Fail. 2023 09; 29(9):1276-1284.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|